caspase 9 inhibitor iii is a synthetic peptide analog incorporating a reactive moiety designed to engage catalytic cysteine sites. The sequence allows investigation of substrate-recognition motifs and protease specificity. Researchers employ it to probe apoptotic signaling pathways and enzyme kinetics. Its tailored structure supports mechanistic studies of caspase activity.
CAT No: HB00092
CAS No:403848-57-7
Synonyms/Alias:403848-57-7;Ac-Leu-Glu-His-Asp-chloromethylketone;Caspase-9 Inhibitor III(Ac-LEHD-CMK);caspase 9 inhibitor iii;FA111088;PD088788;Caspase-9 Inhibitor III(Ac-LEHD-CMK)?;Ac-DL-Leu-DL-Glu-DL-His-DL-Asp-CH2Cl;G85499;4-[(2-acetamido-4-methylpentanoyl)amino]-5-[[1-[(1-carboxy-4-chloro-3-oxobutan-2-yl)amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]amino]-5-oxopentanoic acid;
2. Urinary Metabolites Associated with Blood Pressure on a Low-or High-Sodium Die
3. The spatiotemporal control of signalling and trafficking of the GLP-1R
4. Myotropic activity of allatostatins in tenebrionid beetles
5. Emu oil in combination with other active ingredients for treating skin imperfections
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.